CHIRON CAPITAL MANAGEMENT, LLC

Position in DFTX — Definium Therapeutics, Inc.

CIK 1830922 TALLAHASSEE, FL

Position in DFTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$329,280

New position

Shares Held

7,000

first reported quarter

Ownership

0.005%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#244

of 358 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHIRON CAPITAL MANAGEMENT, LLC holds $1,195,948 across 5 Biotechnology names. DFTX ranks #2 (27.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	5,850	$334,737
2	DFTX	Definium Therapeutics, Inc. This page	7,000	$329,280
3	ATAI	AtaiBeckley Inc.	50,126	$264,164
4	TGTX	Tg Therapeutics, Inc.	3,800	$208,772
5	PGEN	Precigen, Inc.	10,350	$58,995

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$329,280	7,000	—	Shares	Sole	2026-07-21
No filing history on record for this holder in this stock.